Browse Guides  internal medicine  neurology

Stroke

Prevalence
Clinical features
Investigations
Therapy
Prevention
Prognosis
Prevention

Acute ischaemic stroke or transient ischaemic attack

There is no clear benefit from indobufen a

Why?

  • It is not clearly better than warfarin at reducing recurrent strokes, though causes fewer extracranial bleeds. a

Expiry date: October 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   G  Donnan
CAT Writers   CJ   Wotton , N   Shenker , CM   Ball